regulatory hurdles
Coverage of regulatory hurdles in the Nexus archive.
- Why do mainland Chinese firms refuse to give up on Wall Street IPOs?
Amid heightened geopolitical tensions and regulatory hurdles, mainland Chinese companies continue pursuing Wall Street IPOs despite a five-year low in deal volume and proceeds, with only two firms raising $59.5 million in the first half of the year, according to an EY report.
- Can prediction markets win over Wall Street?
The article discusses the challenges prediction markets face in competing with Wall Street, highlighting that overcoming regulatory obstacles is only part of the struggle. It implies further hurdles remain for prediction markets to gain traction in the financial sector.
- Two prominent homebuilders weigh in on where the local industry currently stands
Two prominent homebuilders discuss the challenging state of the local homebuilding industry, citing cautious buyers, elevated construction costs, and ongoing regulatory hurdles as key obstacles.
- Apollo hunts for Japanese life insurer to boost growth
Apollo, a US asset manager, is seeking to acquire a Japanese life insurer to boost growth. However, the company may face regulatory hurdles due to a preference for domestic players in Japan.
- A forgotten drug is giving new hope to kids with a rare disease
A decades-old drug, DFMO, originally used to treat sleeping sickness, is showing promise in treating Bachmann-Bupp syndrome (BABS), an ultra-rare genetic disorder. Early results indicate it may alleviate severe symptoms by addressing the underlying genetic malfunction, though regulatory and logistical challenges slow progress.